Optec International (GRMD) Return on Equity ROE from the second quarter 2019 to second quarter 2018 and annually, average high and low, overall ranking from Dec 31 2018 to Dec 31 2017 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Optec International, Inc.  (GRMD)

Optec International's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Optec International in the second quarter 2019?
Due to the lack of equity, it was not possible to calculate Optec International, Inc.'s return on equity (ROE) in its second quarter 2019

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2018)
II. Quarter		 (Sep 30 2018)
I. Quarter		 (Jun 30 2018)
IV. Quarter		 (Mar 31 2018)
III. Quarter		 (Dec 31 2017)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -5 -3 -1 -1 0
Return On Equity (TTM) - - - - -
GRMD's Total Ranking # # # # #
Equity (TTM) in Millions -4 -2 -1 -1 0
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to GRMD Management Effectiveness >> GRMD's 5 Years Annual ROE >> Compare GRMD ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





GRMD Annual Return On Equity (Jun 30 2018)
2018		 (Jun 30 2017)
2017		 (Jun 30 2016)
2016		 (Jun 30 2015)
2015
Total Equity in Millions -1 0 0 0 0
Y / Y Equity Change - -48.36 % -61.4 % - -
Net Income in Millions -1 0 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity - -93.67 % -159.09 % -20.62 % -

Back to GRMD Management Effectiveness >> GRMD's 5 Years Annual ROE >> Compare GRMD ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
GRMD's' Return on Equity at Yahoo Finance
GRMD's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for GRMD's Competitors
Subscribers only: Roe for Optec International's Suppliers
Subscribers only: Return On Equity for GRMD's Customers




Companies with similar Return On Equity at Dec 31 2018, within Healthcare Sector ROE
Neuropathix Inc.  627.82 %
Bellerophon Therapeutics inc  505.89 %
Zomedica Corp   446.00 %
Tuhura Biosciences Inc   400.93 %
Tricida Inc   396.91 %
Semler Scientific inc   385.69 %
Altamira Therapeutics Ltd   316.71 %
Tenax Therapeutics Inc   277.60 %
Quoin Pharmaceuticals Ltd   259.90 %
Harrow Inc   177.22 %
Iveric Bio Inc   144.20 %
Elite Pharmaceuticals Inc   127.37 %
Zynex inc   122.43 %
Cba Florida Inc   117.88 %
Apyx Medical Corp  110.69 %
Oxford Immunotec Global Plc  110.11 %
Strongbridge Biopharma plc  108.51 %
Trillium Therapeutics Inc   105.66 %
Mettler toledo International Inc   92.58 %
Fonar Corporation  89.72 %
Gsk Plc  86.33 %
Celgene Corp  82.47 %
Check Cap Ltd  81.27 %
Lantheus Holdings Inc   79.17 %
Novo Nordisk A  77.00 %
Exelixis Inc   75.66 %
Tenet Healthcare Corp  75.34 %
Orgenesis Inc   73.55 %
Nrc Health  70.12 %
Zoetis Inc   68.96 %

Date modified: 2026-06-22T16:30:21+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.